Cargando…
Early anti-inflammatory intervention ameliorates axial disease in the proteoglycan-induced spondylitis mouse model of ankylosing spondylitis
BACKGROUND: Ankylosing spondylitis (AS) is characterised by immune-mediated arthritis and osteoproliferation, ultimately leading to joint ankylosis. Whether inflammation is necessary for osteoproliferation is controversial, fuelled by the unclear efficacy of anti-inflammatory treatments on radiograp...
Autores principales: | Tseng, Hsu-Wen, Glant, Tibor T., Brown, Matthew A., Kenna, Tony J., Thomas, Gethin P., Pettit, Allison R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450150/ https://www.ncbi.nlm.nih.gov/pubmed/28558827 http://dx.doi.org/10.1186/s12891-017-1600-7 |
Ejemplares similares
-
Inflammation-driven bone formation in a mouse model of ankylosing spondylitis: sequential not parallel processes
por: Tseng, Hsu-Wen, et al.
Publicado: (2016) -
Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitors
por: Haynes, Katelin R, et al.
Publicado: (2012) -
Treatment of a mouse model of ankylosing spondylitis with exogenous sclerostin has no effect on disease progression
por: Haynes, Katelin R., et al.
Publicado: (2015) -
Microbes, the gut and ankylosing spondylitis
por: Costello, Mary-Ellen, et al.
Publicado: (2013) -
Axial spondyloarthritis including ankylosing spondylitis
por: Braun, Jürgen
Publicado: (2018)